Does INFLIXIMAB Cause Neoplasm malignant? 892 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 892 reports of Neoplasm malignant have been filed in association with INFLIXIMAB (Renflexis). This represents 0.6% of all adverse event reports for INFLIXIMAB.
892
Reports of Neoplasm malignant with INFLIXIMAB
0.6%
of all INFLIXIMAB reports
114
Deaths
138
Hospitalizations
How Dangerous Is Neoplasm malignant From INFLIXIMAB?
Of the 892 reports, 114 (12.8%) resulted in death, 138 (15.5%) required hospitalization, and 40 (4.5%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 892 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
DENOSUMAB (698)
Which INFLIXIMAB Alternatives Have Lower Neoplasm malignant Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT